查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年失禁设备的全球市场
市场调查报告书
商品编码
1176601

2023-2030 年失禁设备的全球市场

Global Incontinence Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内（2023 年至 2030 年），失禁设备的市场规模预计将以 6.4% 的复合年增长率增长。

尿失禁是指尿液不自觉地从膀胱排出（尿失禁）或排便（大便失禁）。 指的是 尿失禁是一种广泛存在的疾病，影响着全世界 2 亿人。 尿失禁在女性中的发生率是男性的两倍。

市场动态

推动全球失禁设备市场的主要因素是全球慢性病（例如膀胱过度活动症和肾结石）的增加、研发支出的增加以及老年人口的快速增长。 新产品推出的增加促进了失禁治疗市场的增长。

与慢性病相关的失禁增加以及技术先进产品的推出预计将推动市场增长。

对这些失禁设备产品的研究不断增加，以及老年人膀胱过度活动症等膀胱疾病的患病率不断增加，将推动市场增长。 世界上慢性病的增加也推动了市场的增长。 根据美国疾病控制和预防中心 (CDC) 的数据，慢性肾脏病 (CKD) 在 45-64 岁 (13%) 和 65 岁以上 (38%) 人群中比 18-44 岁人群 (7%) 更常见). 我来了。 许多医疗保健公司正在加紧研发工作，以开发新颖、创新和技术先进的产品。

推动市场增长的关键因素包括患有泌尿系统疾病的老年人口增加、与肾结石等慢性病相关的失禁增加，以及创新设备的可用性增加。 此外，主要製造商增加新产品的研发和技术先进的产品供应也有望在市场增长中发挥重要作用。

各种新产品的发布、监管批准和研究都为市场的增长做出了贡献。 例如，2021 年 11 月 10 日，开发治疗压力性尿失禁和盆腔器官脱垂手术产品的医疗器械公司 Caldera Medical 宣布批准了一款用于治疗压力性尿失禁的新产品 Desara TVez。 此次发布增加了 Cladella 最广泛的产品组合，这些产品组合适用于苦苦应对压力性尿失禁治疗方案的女性。

与失禁手术相关的风险预计会阻碍市场增长。

但是，与失禁手术相关的风险包括暂时性排尿困难、尿路感染、膀胱过度活动症、腹股沟疼痛以及手术材料伸入阴道。 这些因素可能会阻碍市场增长。

缺乏认可度也是製约市场成长的一大因素。 在低收入国家，人们不知道失禁设备的使用，而且缺乏报销方案阻碍了市场增长。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了积极影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 Covid，膀胱过度活动症治疗市场取得了巨大收益。 在 Covid 患者中也观察到与膀胱相关的问题，例如膀胱过度活动症。 Covid 影响了患者的膀胱。 主要製造商已经启动了各种研究和临床试验。 世界各地正在开展各种举措、产品发布、合作和合併，推动市场增长。 例如，2022 年 7 月，Urovant Science 宣布与 Pierre Fabre Medicament 达成许可协议，在欧洲地区将用于治疗膀胱过度活动症的 Vibegron 商业化。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 与慢性病相关的尿失禁增加
      • 更多地推出技术先进的产品
    • 约束因素
      • 与失禁手术相关的风险
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 导尿管
    • 导尿管
    • 其他导尿管
  • 电刺激器
  • 阴道吊带
    • 常规阴道吊带
    • 高级阴道吊带
    • 生物素
    • 其他
  • 人工尿道括约肌

第 8 章按类别

  • 口腔失禁治疗装置
  • 内部尿失禁装置

第 9 章失禁类型

  • 压力性尿失禁
  • 急迫性尿失禁
  • 溢出性尿失禁
  • 功能性尿失禁

第 10 章最终用户

  • 医院
  • 诊所
  • 家庭护理

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第13章公司简介

  • B.Braun Melsungen AG
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • ConvaTec Inc.
  • Coloplast Corp
  • BD
  • Promedon GmbH
  • Medtronic Plc
  • Wellspect HealthCare（Dentsply Sirona）
  • Hollister Incorporated
  • A.M.I. GmbH
  • Caldera Medical

第14章 DataM

简介目录
Product Code: DMMD53

Market Overview

Incontinence Devices Market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.4% during the forecast period (2023-2030).

Incontinence refers to involuntary loss of urine from the bladder (urinary incontinence) or bowel motion, feces, or wind from the bowel (fecal or bowel incontinence). Urinary incontinence is a widespread medical condition that affects 200 million people worldwide. Urinary Incontinence is twice as common in women as in men.

Market Dynamics

The major factors driving the global incontinence devices market are an increase in chronic diseases such as overactive bladder or kidney stones globally, rising research and development expenditure and a surge in the geriatric population. An increase in novel product launches contributed to the growth of the incontinence devices market.

Increased incontinence associated with chronic conditions and technologically advanced product launches is expected to drive the market's growth.

The rising research on these incontinence device products and the growth in the prevalence of bladder disorders such as overactive bladder in the geriatric population will drive the market growth. An increase in chronic diseases globally is also aiding market growth. Chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%), according to the Centers for Disease Control and Prevention (CDC). There has been an increase in R&D activities by many healthcare companies to develop novel, innovative and technologically advanced products.

The key factors boosting the market growth include the rise in the geriatric population that suffers from urological conditions, the increase in incontinence associated with chronic conditions such as kidney stones and the availability of innovative devices. Moreover, the increase in research and development of novel products and the availability of technologically advanced products by key players are also expected to play a vital role in the market's growth.

Various novel product launches, regulatory approvals and research studies contribute to the market's growth. For instance, in November 10, 2021, Caldera Medical, a medical device company developing surgical products for stress urinary incontinence treatment and Pelvic Organ Prolapse, announced its clearance for the novel Desara TVez for treating stress urinary incontinence. This launch further expands Cladera's broadest product portfolio for women suffering from stress urinary incontinence treatment options.

The risks associated with incontinence surgery are expected to hamper the market's growth.

However, the risks associated with incontinence surgery include temporary difficulty urinating, urinary tract infection, development of an overactive bladder, groin pain and surgical material sticking out into the vagina. These factors may hinder the growth of the market.

Lack of awareness is also a leading factor restraining the market's growth. In low-income countries, people are unaware of incontinence device usage, and the unavailability of reimbursement scenarios hinders the market's growth.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The overactive bladder treatment market has experienced huge profits due to COVID. In covid patients, bladder-related problems such as overactive bladder were also observed. COVID affected the bladders of patients. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2022, Urovant Sciences announced its license agreement with Pierre Fabre Medicament for Vibegron commercialization for overactive bladder treatment in European Areas.

Segment Analysis

The electrical stimulation devices segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The electrical stimulation devices segment is the highest market holder in the global incontinence devices market. The global incontinence devices market is segmented based on product type as urinary catheters, electrical stimulation devices, vaginal slings, and artificial urinary sphincters. The electrical stimulation device segment is the largest market shareholder due to its high demand, advantages and usage, rising adoption of these incontinence devices, better results in bladder disorder patients and increased research and development activities, which are expected to remain high during the forecast period.

The electrical stimulation device or neurostimulation device utilizes an electrode that is implanted under the skin to stimulate nerves with electricity around the bladder. The electric signals traveling from the bladder to the brain are blocked with electricity reducing the symptoms of an overactive bladder are blocked. These therapies are of two types: sacral neuromodulation and percutaneous tibial nerve stimulation.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in April 2021, Medtronic, the medical technology company, announced receiving approval from the United States Food and Drug Administration to continue the investigational device exemption trial for evaluating its implantable tibial neuromodulation device, an internally developed therapy specially developed for bladder incontinence symptom's relief.

Geographical Analysis

North America holds the largest market share in the global incontinence devices market.

North America dominates the global incontinence devices market, primarily due to its large population, excellent medical infrastructure, and rising number of bladder-related disorders. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure. As per the National Association for Incontinence (NAFC), in North America, nearly 200 million people were affected by urinary incontinence in 2021. According to WomensHealth.gov, urinary incontinence is twice as common in men, whereas stress urinary incontinence is most common in pregnant women, giving birth and going through menopause.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of products for different types of incontinence, including stress incontinence, urge incontinence, overflow incontinence, functional incontinence, increase in pharmaceutical establishment across the region, government approvals, and key players in the region are contributing to the growth of the incontinence devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, regulatory approvals, technological advancements, collaborations, and agreements are taking place in this region. In Oct 2020, Essity health and hygiene company launched TENA SmartCare. It is a novel, reusable digital sensor for better incontinence care. It will be available for working professionals and home caregivers.

Competitive Landscape

The incontinence devices market is moderately competitive with local and global companies' presence. B. Braun Melsungen AG, ConvaTec Inc., Coloplast Corp, BD, Promedon GmbH, Medtronic Plc, Wellspect HealthCare (Dentsply Sirona), Hollister Incorporated, A.M.I. GmbH, Caldera Medical and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in August 11, 2022, A.M.I. GmbH announced its partnership with Medistim Norge AS, an established provider of medical devices for Norwegian health institutions. This collaboration will extend Norge's product portfolio in urogynecology, coloproctology, and urology and will provide products and solutions for incontinence, pelvic organ prolapses and hemorrhoid patients.

B. Braun Melsungen AG.

Overview: B. Braun is a company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and founded in 1839. They provide services in around 60 countries that employ around 63,000 people. They have around 5,000 varieties of healthcare products.

Product Portfolio:

Actreen Mini Cath: Actreen Mini Cath is a urinary catheter that is short and specially designed for the self-catheterization of females. It is a modern and feminine design and is ready to use as a catheter.

The global incontinence devices market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased incontinence associated with chronic conditions
      • 4.1.1.2. Rising technologically advanced product launches
    • 4.1.2. Restraints:
      • 4.1.2.1. Risks associated with incontinence surgery
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Urinary Catheters *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Foley Catheters
    • 7.2.4. Other Urinary Catheters
  • 7.3. Electrical Stimulation Devices
  • 7.4. Vaginal Slings
    • 7.4.1. Conventional Vaginal Slings
    • 7.4.2. Advanced Vaginal Slings
    • 7.4.3. Biotin
    • 7.4.4. Others
  • 7.5. Artificial Urinary Sphincters

8. By Category

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 8.1.2. Market Attractiveness Index, By Category
  • 8.2. External Urinary Incontinence Devices *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Internal Urinary Incontinence Devices

9. By Incontinence Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 9.1.2. Market Attractiveness Index, By Incontinence Type
  • 9.2. Stress Incontinence *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Urge Incontinence
  • 9.4. Overflow Incontinence
  • 9.5. Functional Incontinence

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Homecare

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. B. Braun Melsungen AG *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. ConvaTec Inc.
  • 13.3. Coloplast Corp
  • 13.4. BD
  • 13.5. Promedon GmbH
  • 13.6. Medtronic Plc
  • 13.7. Wellspect HealthCare (Dentsply Sirona)
  • 13.8. Hollister Incorporated
  • 13.9. A.M.I. GmbH
  • 13.10. Caldera Medical

LIST NOT EXHAUSTIVE

14. Global Incontinence Devices Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and End-User
  • 14.3. Contact Us